Soleno Therapeutics SLNO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 67.60 | 495 | 7.08 | 26 | 5.58 | 600 |
| 2025Q2 | 83.78 | 240 | -1.99 | -5 | -1.45 | 332 |
| 2025Q1 | 71.45 | 232 | -18.34 | -44 | -13.49 | 318 |
| 2024Q4 | 44.95 | 245 | -21.96 | -56 | -17.84 | 331 |
| 2024Q3 | 50.49 | 265 | -28.09 | -77 | -25.50 | 297 |
| 2024Q2 | 40.80 | 281 | -10.31 | -22 | -9.24 | 304 |
| 2024Q1 | 42.80 | 143 | -14.22 | -21 | -12.24 | 169 |
| 2023Q4 | 40.25 | 158 | -12.50 | -11 | -9.25 | 181 |
| 2023Q3 | 29.51 | 23 | -60.94 | -11 | -22.99 | 64 |
| 2023Q2 | 4.29 | 12 | -112.51 | -8 | -33.58 | 31 |
| 2023Q1 | 2.14 | 3 | -128.68 | -8 | -36.31 | 20 |
| 2022Q4 | 1.98 | 10 | -42.95 | -5 | -18.76 | 26 |
| 2022Q3 | 1.67 | 15 | -34.54 | -6 | -17.82 | 32 |
| 2022Q2 | 2.77 | 20 | -28.76 | -7 | -16.94 | 37 |
| 2022Q1 | 3.35 | 26 | -25.87 | -6 | -14.66 | 43 |
| 2021Q4 | 6.15 | 18 | -14.89 | -3 | -7.24 | 36 |
| 2021Q3 | 13.87 | 20 | -34.17 | -8 | -17.82 | 43 |
| 2021Q2 | 17.10 | 27 | -33.81 | -11 | -20.83 | 49 |
| 2021Q1 | 18.90 | 38 | -21.55 | -9 | -14.72 | 57 |
| 2020Q4 | 28.95 | 46 | -6.10 | -3 | -4.17 | 65 |